1-Bromo-3-(2-ethoxyethoxy)benzene, 5g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95%, 10g

2-Amino-5-(2,2,2-trifluoroethyl)thiophene-3-carboxamide, 98%, 100mg

2-Chloro-5-fluoro-3-(trifluoromethyl)benzoic acid, 97%, 500mg

Ácido 6-aminohexanoico, mínimo 99 %, para síntesis, 500 g, envase de plástico.

N-(2-Oxotetrahydrothiophen-3-yl)acetamide, 95.0%, 250mg

6-Chloropyridazine-3-carbonitrile, 97.0%, 25g

[3,4-(Methylenedioxy)phenyl]glyoxylic acid, 97.0%, 100mg

4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine, 95.0%, 5g

N-Boc-Ethane-1,2-diamine hydrochloride, 95.0%, 10g

Methyl 5-bromosalicylate, 95.0%, 50g

2-Bromo-5-(trifluoromethyl)benzodifluoride (stabilized over Potassium carbonate), 1g

4-Methoxyoxane-4-carboxylic acid, 98+%, 1g